Meridian Bioscience Inc (NASDAQ:VIVO)

Delayed Data
As of Jan 21
 +0.32 / +1.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 45.00, with a high estimate of 62.00 and a low estimate of 28.00. The median estimate represents a +111.76% increase from the last price of 21.25.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Meridian Bioscience Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.22%
Growthannually -37.65%


Growthquarterly -3.22%
Growthannually -7.60%
Key to the earnings and sales forecast charts.